Table 4.
Pharmacodynamic Parameters after Topical Application of Single Dose of Different Pregabalin Formulations to Dutch Belted Rabbitsa
| ophthalmic eye drops | |||||
|---|---|---|---|---|---|
| pharmacodynamic parameters | PRGb chitosan MEc | PRG sodium alginate ME | PRG Carbopol 981 ME | PRG in Carbopol 981 | PRG W/O ME |
| baseline IOPd | 21.2 ± 0.4 | 20.9 ± 0.2 | 21.4 ± 0.7 | 22.1 ± 0.4 | 16.7 ± 1.2 |
| IOP at Tmaxe | 13.9 ± 1.0 | 13.6 ± 0.2 | 12.3 ± 0.5 | 15.7 ± 0.4 | 12.7 ± 0.7 |
| ΔIOP | −7.3 ± 1.3 | −7.3 ± 0.4 | −9.1 ± 0.8 | −6.5 ± 0.4 | −4.0 ± 0.58 |
| % reduction in IOP | 34.1 ± 5.4 | 35.0 ± 1.7 | 42.3 ± 2.6 | 29.4 ± 1.4 | 23.8 ± 1.9 |
| Tmax (h) | 4.0 ± 1.0 | 3.7 ± 0.3 | 3.3 ± 0.9 | 3.3 ± 1.5 | 2.33 ± 0.33 |
| Tendf (h) | 20.0 ± 0.0 | 24.0 ± 0.0 | 32.7 ± 1.3 | 9.3 ± 0.7 | 7.33 ± 1.33 |
| AUCg (%. H) | 323.0 ± 27.0 | 384.3 ± 21.2 | 788.6 ± 36.8 | 172.3 ± 16.9 | 98.9 ± 13.8 |
Data are expressed as mean ± SEM; n = 3.
PRG: pregabalin.
ME: microemulsion.
IOP: intraocular pressure.
Tmax: time to maximum response in hours.
Tend (h): time to end of response in hours.
AUC (%. H): total area under % IOP reduction versus time curve